Pilot Study of Transcranial Direct Current Stimulation (tDCS)

Completed · Not applicable · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

This study will test the tolerability and preliminary efficacy of transcranial direct current stimulation (tDCS) combined with a cognitive training program, remotely-delivered using a telemedicine protocol in 60 adults with multiple sclerosis (MS). The study will evaluate the efficacy of tDCS to evaluate two of the most debilitating symptoms of MS: cognitive impairment and fatigue.

Key facts

Study ID

NCT02746705

Run by

NYU Langone Health

People needed

31

Starts

2016-04-01

Expected to finish

2018-09-30

Last updated by the study team

2020-05-08

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 18-70
• Definite MS diagnosis, all subtypes [95]
• MS-related changes in cognitive functioning
• A score of 6.5 or lesson the Expanded
• Disability Status Scale (EDSS) OR more than 6.5 with proxy
• Has stable and continuous access to internet service at home compatible with the study laptop (Wi-Fi or ethernet cable)
• Adequate internet capacity for remote monitoring, as tested by http://www.speedtest.net/)
• Adequate home facilities (enough space, access to quiet and distraction free area)
• Able to commit to the two-week period of training sessions with baseline and follow-up visits.
• Able to understand the informed consent process and provide consent to participate in the study

You may not qualify if…

• Visual, auditory and motor deficits that would prevent full ability to understand study instructions or operate the tDCS device or study laptop, as judged by treating neurologist or study staff
• Relapse or steroid use in previous month
• History of mental retardation, pervasive developmental disorder or other neurological condition associated with cognitive impairment
• Primary psychiatric disorder that would influence ability to participate
• History of seizures or seizure disorder
• Current chronic headaches or migraines. In addition, if a subject has had a change in the rate or severity of head pressure, headache, or migraine in the past two weeks, they are excluded.
• History of head trauma (e.g., head injury, brain surgery) or medical device implanted in the head (such as Deep Brain Stimulator) or in the neck (such as a Vagus Nerve Stimulator)
• Any skin disorder/sensitive skin (e.g., eczema, severe rashes), blisters, open wounds, burn including sunburns, cuts or irritation, or other skin defects which compromise the integrity of the skin at or near stimulation locations (where electrodes are placed)
• Treatment for a communicable skin disorder currently or over the past 12 months

Where it is running

• New York University Langone Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.